Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 3 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Enanta Pharmaceuticals Inc have a median target of 22.00, with a high estimate of 30.00 and a low estimate of 12.00. The median estimate represents a 98.74% increase from the last price of 11.07.
High | 171.0% | 30.00 |
Med | 98.7% | 22.00 |
Low | 8.4% | 12.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 25, 2024.
Average growth rate | +10.97% |
Average growth rate | -58.43% |
More ▼
Revenue history & estimates in USD
Average growth rate | -1.15% |
Average growth rate | -20.09% |
More ▼